Neuraxis Inc Quick Ratio (NRXS) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Neuraxis Inc   (NYSEAMER: NRXS)

Neuraxis Inc 's Quick Ratio

NRXS's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Neuraxis Inc 's Cash & cash equivalent grew by 17.85 % in the Q2 2026 sequentially, faster than Current Liabilities, this led to improvement in Neuraxis Inc 's Quick Ratio to 2.69 a new company high.

Within Medical Equipment & Supplies industry 66 other companies have achieved higher Quick Ratio than Neuraxis Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 926 to 1191.

Explain Quick Ratio?
How much Cash & cash equivalents NRXS´s has?
What are NRXS´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NRXS Quick Ratio (Jun 30 2026)
Q2		 (Mar 31 2026)
Q1		 (Dec 31 2025)
Q4		 (Sep 30 2025)
Q3		 (Jun 30 2025)
Q2
Y / Y Current Liabilities Change 36.36 % 33 % 14.74 % 15.43 % -70.1 %
Y / Y Cash & cash equivalent Change 38.84 % 249.47 % 33.58 % 1457.42 % 240.38 %
Quick Ratio MRQ 2.69 2.62 1.83 1.42 2.65
NRXS's Total Ranking # 1191 # 926 # 915 # 1222 # 534
Seq. Current Liabilities Change 14.8 % -0.46 % -11.89 % 35.43 % 11.97 %
Seq. Cash & cash equivalent Change 17.85 % 42.57 % 13.43 % -27.15 % 196.64 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 67
Healthcare Sector # 426
Overall Market # 1191


Quick Ratio Statistics
High Average Low
2.69 1.04 0
(Jun 30 2026)   (Jun 30 2023)




Financial Statements
Neuraxis Inc 's Current Liabilities $ 3 Millions Visit NRXS's Balance sheet
Neuraxis Inc 's Cash & cash equivalent $ 8 Millions Visit NRXS's Balance sheet
Source of NRXS's Sales Visit NRXS's Sales by Geography


Cumulative Neuraxis Inc 's Quick Ratio

NRXS's Quick Ratio for the trailling 12 Months

NRXS Quick Ratio

 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 24.17 % -26.59 % -38.65 % -38.78 % -39.83 %
Y / Y Cash & cash equivalent TTM Growth 105.81 % 187.97 % 197.28 % 630.9 % 347.82 %
Quick Ratio TTM 2.14 2.09 1.72 1.66 1.29
Total Ranking TTM # 3807 # 2808 # 2457 # 2953 # 2710
Seq. Current Liabilities TTM Growth 7.68 % 6.64 % 3.58 % 4.41 % -36.34 %
Seq. Cash & cash equivalent TTM Growth 10.41 % 29.08 % 7.74 % 34.04 % 54.48 %

Quick ratio ranking by company, industry and sector >> Back to NRXS Financial Strength Comparisons >> Go to Compare NRXS Quick Ratio to its Competitors

On the trailing twelve months basis NRXS Cash & cash equivalent grew by 38.84 % in Q2 2026 year on year, faster than Current Liabilities, this led to increase in in Neuraxis Inc 's Quick Ratio to 2.14, above NRXS average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 197 other companies have achieved higher Quick Ratio than Neuraxis Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 2808 to 3807.

Explain Quick Ratio?
How much Cash & cash equivalents NRXS´s has?
What are NRXS´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 198
Healthcare Sector # 879
Within the Market # 3807


trailing twelve months Quick Ratio Statistics
High Average Low
2.09 0.9 0.05
(Jun 30 2026)   (Mar 31 2024)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Safe Pro Group Inc   7.24 $ 10.231  Millions$ 1.413  Millions
Delcath Systems Inc   7.22 $ 95.902  Millions$ 13.279  Millions
Streamex Corp   7.16 $ 18.586  Millions$ 2.595  Millions
Endra Life Sciences Inc  7.04 $ 5.540  Millions$ 0.787  Millions
Iradimed Corporation  6.45 $ 59.080  Millions$ 9.164  Millions
Orasure Technologies Inc  6.39 $ 160.582  Millions$ 25.119  Millions
Alpha Pro Tech Ltd   5.94 $ 18.901  Millions$ 3.180  Millions
Si bone inc   5.89 $ 141.519  Millions$ 24.042  Millions
Dexcom Inc   5.84 $ 1,107.000  Millions$ 189.500  Millions
Cvrx inc   5.78 $ 64.586  Millions$ 11.177  Millions
Carlsmed Inc   5.67 $ 70.244  Millions$ 12.397  Millions
Profound Medical Corp   5.24 $ 38.271  Millions$ 7.304  Millions
Rxsight Inc   5.03 $ 404.247  Millions$ 80.444  Millions
Transmedics Group Inc   4.81 $ 472.675  Millions$ 98.283  Millions
Aethlon Medical Inc   4.76 $ 4.934  Millions$ 1.036  Millions
Bluejay Diagnostics Inc  4.53 $ 9.599  Millions$ 2.117  Millions
Hyperfine Inc   4.51 $ 43.458  Millions$ 9.629  Millions
Innovative Eyewear Inc   4.36 $ 2.455  Millions$ 0.563  Millions
Autonomix Medical Inc   4.23 $ 3.460  Millions$ 0.818  Millions
Sharps Technology Inc   4.16 $ 12.071  Millions$ 2.903  Millions
Trisalus Life Sciences Inc   4.14 $ 46.288  Millions$ 11.172  Millions
Kestra Medical Technologies Ltd   4.12 $ 198.911  Millions$ 48.269  Millions
Sight Sciences Inc   3.89 $ 79.753  Millions$ 20.499  Millions
Irhythm Holdings Inc   3.82 $ 839.951  Millions$ 219.981  Millions
Nutriband Inc   3.77 $ 3.422  Millions$ 0.907  Millions
Logicmark Inc  3.71 $ 6.596  Millions$ 1.779  Millions
Axogen inc   3.67 $ 111.412  Millions$ 30.374  Millions
Procept Biorobotics Corporation  3.60 $ 230.952  Millions$ 64.196  Millions
Heartbeam Inc   3.54 $ 8.700  Millions$ 2.460  Millions
Mimedx Group Inc   3.53 $ 135.839  Millions$ 38.498  Millions

Date modified: 2026-09-12T06:26:59+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.